Bleomycin 15 Units Injection

Bleomycin 15 Units is an antitumour antibiotic used in selected lymphoma, testicular and squamous-cell cancer regimens. A separate intrapleural use can help control malignant pleural fluid.
The clinical team reconstitutes and administers the medicine by the route required for the regimen, commonly intravenous and in selected settings intramuscular, subcutaneous or intrapleural.
Bleomycin forms a metal–oxygen complex that generates reactive species and causes breaks in DNA strands.
Fever, chills, skin pigmentation, rash, mouth soreness and nail changes can occur. Pneumonitis and pulmonary fibrosis are the most important potentially serious toxicities.
Report a new dry cough or breathlessness promptly. Tell any anaesthesia team about previous bleomycin because oxygen and fluid management require particular care.
DNA injury can help control susceptible tumours. Intrapleural treatment promotes pleural adhesion to reduce recurrent malignant fluid.
Bleomycin can inflame and scar lung tissue. Early changes may require stopping the drug before further injury develops.
Bleomycin alone generally causes less marrow suppression than many cytotoxic drugs, but combination chemotherapy still affects blood counts.
Mention previous bleomycin exposure even if treatment finished long ago, because pulmonary risk can remain relevant.
The kidneys remove much of the medicine. Reduced kidney function can cause bleomycin to remain in the body longer, increasing toxicity, including lung injury. Kidney results therefore help determine the treatment plan.
Antitumour antibiotic: a cytotoxic medicine originally derived from microbial products. Pulmonary fibrosis: lung scarring. Pleurodesis: adhesion of pleural surfaces to reduce fluid reaccumulation.; AR: Bleomycin 15 Units حقن; FR: Bleomycin 15 Units injection; PT: Bleomycin 15 Units injeção; ES: Bleomycin 15 Units inyección; RU: Bleomycin 15 Units инъекция; ID: Bleomycin 15 Units suntikan; VI: Bleomycin 15 Units thuốc tiêm; MS: Bleomycin 15 Units suntikan; TL: Bleomycin 15 Units iniksyon; ZH-SG: Bleomycin 15 Units 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Bleomycin 15 Units Injection under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Bleomycin 15 Units Injection